PECAM1 and neoplasm: We used CD31 as a blood vessel marker to assess the distribution of neutrophils (Ly6G+ and exhibited segmented cell nuclei as shown in ROI I in Fig. 4g) in the vessels and in the tumor interstitium, respectively (Fig. 4h).